Ignacio, M. (2023). Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: A subset analysis of the phase 3, randomized, controlled ASPECT-NP trial. Springer.
Chicago Style CitationIgnacio, Martin-Loeches. Outcomes in Participants With Ventilated Nosocomial Pneumonia and Organ Failure Treated With Ceftolozane/tazobactam Versus Meropenem: A Subset Analysis of the Phase 3, Randomized, Controlled ASPECT-NP Trial. Springer, 2023.
MLA CitationIgnacio, Martin-Loeches. Outcomes in Participants With Ventilated Nosocomial Pneumonia and Organ Failure Treated With Ceftolozane/tazobactam Versus Meropenem: A Subset Analysis of the Phase 3, Randomized, Controlled ASPECT-NP Trial. Springer, 2023.